Get 40% Off
☕ Buy the dip? After losing 17%, Starbucks sees an estimated 20% upside. See the top Undervalued stocks!Unlock list

ThyssenKrupp's Nucera valued at 2.5 billion euros in IPO

Published 05/07/2023, 19:05
Updated 05/07/2023, 19:15
© Reuters. The logo of Thyssenkrupp Nucera, one of Europe's biggest IPOs this year, is pictured at the headquarters of Thyssenkrupp's hydrogen division in Dortmund, Germany July 4, 2023. REUTERS/Stephane Nitschke

(Reuters) - Hydrogen firm ThyssenKrupp Nucera has priced its initial public offering at 20 euros ($21.72) per share, implying a market capitalisation of around 2.5 billion euros, the company said in a statement on Wednesday.

The company and its shareholders, Germany's ThyssenKrupp and Italy's De Nora, expect to raise up to 605 million euros through the IPO, making it one of Europe's largest so far this year.

The stock is due to start trading on Friday on the Frankfurt Stock Exchange.

"We are proud that in terms of placement volume ThyssenKrupp Nucera is the largest global hydrogen IPO of all times," Nucera's chief executive, Werner Ponikwar, said in the statement.

The final pricing of 20 euros per share comes in the middle of the indicative price range of 19-21.5 euros, though well below earlier expectations of a price that would have implied a market cap in excess of 3 billion euros.

About a third of the shares on sale were previously allocated to Saudi Arabia's Public Investment Fund (PIF) and BNP Paribas (EPA:BNPP)' Energy Transition Fund ahead of launch.

Nucera's IPO is part of a wave of European companies aiming to go public before investors shut up shop for the summer, including Hidroelectrica in Romania and CAB Payments in Britain.

Bankers hope the transactions will herald a stronger recovery in new listings in the coming months, but how companies perform once they start trading will be closely watched.

The IPO will be the first in Germany since February, when shares in web hosting company IONOS debuted in Frankfurt, as stock market volatility and an uncertain economic outlook have put other company listings on the back burner.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

($1 = 0.9208 euros)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.